A PHASE 1 STUDY OF A THIRD-GENERATION ONCOLYTIC HSV-1 G47Δ IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER

被引：1
|
作者：
Fukuhara, Hiroshi
Takeshima, Yuta
Homma, Yukio
Ino, Yasushi
Todo, Tomoki
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.399
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD28-12
引用
收藏
页码：E658 / E659
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF A THIRD GENERATION ONCOLYTIC HSV-1 G47Δ FOR HEPATOCELLULAR CARCINOMA
    Yamada, Tomoharu
    Ino, Yasushi
    Iwai, Miwako
    Koike, Kazuhiko
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 1124 - 1124
  • [2] THIRD GENERATION ONCOLYTIC HSV-1 (G47Δ) IS HIGHLY EFFICACIOUS FOR MALIGNANT PLEURAL MESOTHELIOMA
    Takahashi, Masamichi
    Ino, Yasushi
    Todo, Tomoki
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1032 - 1033
  • [3] Therapeutic Efficacy of a Third Generation Oncolytic HSV-1 G47 δ in Multiple Mouse Models of Gastric Carcinoma
    Sugawara, Kotaro
    Ino, Yasushi
    Iwai, Miwako
    Seto, Yasuyuki
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 424 - 424
  • [4] A Third Generation Oncolytic HSV-1 G47Δ Enhances the Efficacy of Radiofrequency Ablation Therapy of Hepatocellular Carcinoma
    Yamada, Tomoharu
    Ino, Yasushi
    Iwai, Miwako
    Koike, Kazuhiko
    Todo, Tomoki
    MOLECULAR THERAPY, 2018, 26 (05) : 202 - 202
  • [5] Therapeutic Efficacy of Third Generation Oncolytic HSV-1 (G47Δ) for Glioma Cells with Stem Cell Property
    Ito, Hirotaka
    Ino, Yasushi
    Todo, Tomoki
    MOLECULAR THERAPY, 2016, 24 : S263 - S263
  • [6] The Efficacy of Oncolytic HSV-1 (G47Δ) for Biliary Tract Cancer in Mouse Models
    Tateno, Yoko
    Ino, Yasushi
    Iwai, Miwako
    Shinozaki, Masaru
    Todo, Tomoki
    MOLECULAR THERAPY, 2018, 26 (05) : 347 - 348
  • [7] The Efficacy and Bio-Distribution of Oncolytic HSV-1 (G47Δ) in Mouse Orthotopic Esophageal Cancer Models
    Yajima, Shoh
    Ino, Yasushi
    Fukuhara, Hiroshi
    Iwai, Miwako
    Seto, Yasuyuki
    Todo, Tomoki
    MOLECULAR THERAPY, 2016, 24 : S163 - S163
  • [8] A third generation oncolytic HSV-1 G47. enhances the efficacy of radiofrequency ablation therapy
    Yamada, Tomoharu
    Ino, Yasushi
    Iwai, Miwako
    Koike, Kazuhiko
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 378 - 378
  • [9] Enhanced efficacy of immune checkpoint inhibitors when used in combination with oncolytic HSV-1 G47Δ in lung cancer
    Sakata, Yoshinori
    Ino, Yasushi
    Iwai, Miwako
    Ikeda, Norihiko
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 917 - 917
  • [10] Anti-PD-1 antibody enhances antitumor efficacy of oncolytic HSV-1 G47 Δ in a mouse lung cancer model
    Sakata, Yoshinori
    Ino, Yasushi
    Iwai, Miwako
    Ikeda, Norihiko
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 1185 - 1185
12345